Anirban Goutam Mukherjee

Dr. Anirban Goutam Mukherjee

Department of Biomedical Sciences, Vellore Institute of Technology, Vellore, Vellore, India
orcid
Research Fellow, School of Bio Sciences and Technology, Vell...

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
PBPragya Bradu
Pragya Bradu
ABAntara Biswas
Antara Biswas
CNChandralekha Nair
Chandralekha Nair
SSSalini Sreevalsakumar
Salini Sreevalsakumar
MPMegha Patil
Megha Patil
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan

1 May 2023 in Genes & Diseases
Verified
Journal Article
Open access
HPHafiza Hafiza Padinharayil
Hafiza Hafiza Padinharayil
JVJinsu Varghese
Jinsu Varghese
MJMithun Chacko John
Mithun Chacko John
RKRajanikant G. K.
Rajanikant G. K.
Cornelia M WilsonCornelia M Wilson
Cornelia M Wilson
AGAlex George
Alex George
Continuous revision of the histologic and stage-wise classification of lung cancer by the World Health Organization (WHO) provides the foundation for therapeutic advances by promoting molecular targeted and immunotherapies and ensuring accurate diagnosis. Cancer epidemiologic data provide helpful information for cancer prevention, diagnosis, and management, supporting health-care interventions. Global cancer mortality projections from 2016 to 2060 show that cancer will overtake ischemic heart diseases (IHD) as the leading cause of death (18.9 million) immediately after 2030, surpassing non-small cell lung cancer (NSCLC), which accounts for 85 percent of lung cancers. The clinical stage at the diagnosis is the main prognostic factor in NSCLC therapies. Advanced early diagnostic methods are essential as the initial stages of cancer show reduced mortality compared to the advanced stages. Sophisticated approaches to proper histological classification and NSCLC management have improved clinical efficiency. Although immune checkpoint inhibitors (ICIs) and targeted molecular therapies have refined the therapeutic management of late-stage NSCLC, the specificity and sensitivity of cancer biomarkers should be improved by focusing on prospective studies, followed by their use as therapeutic tools. The liquid biopsy candidates such as circulating tumor cells (CTCs), circulating cell-free tumor DNA (cfDNA), tumor educated platelets (TEP), and extracellular vesicles (EVs) possess cancer-derived biomolecules and aid in tracing: driver mutations leading to cancer, acquired resistance caused by various generations of therapeutic agents, refractory disease, prognosis, and surveillance.

28 March 2022 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
UWUddesh Ramesh Wanjari
Uddesh Ramesh Wanjari
KRKaviyarasi Renu
Kaviyarasi Renu
BVBalachandar Vellingiri
Balachandar Vellingiri
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan

1 November 2021 in Journal of Environmental Management
Verified
Journal Article
Closed access
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
UWUddesh Ramesh Wanjari
Uddesh Ramesh Wanjari
RCRituraj Chakraborty
Rituraj Chakraborty
KRKaviyarasi Renu
Kaviyarasi Renu
BVBalachandar Vellingiri
Balachandar Vellingiri
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan

9 January 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
KRKaviyarasi Renu
Kaviyarasi Renu
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
SVSathishkumar Vinayagam
Sathishkumar Vinayagam
Raja GanesanRaja Ganesan
Raja Ganesan
Heavy metal and metalloid poisoning in the environment and food has piqued the public’s interest since it poses significant hazards to the ecological system and human health. In food, several metals, including cadmium (Cd), lead (Pb), mercury (Hg), tin (Sn), manganese (Mn), and aluminium (Al), and metalloids, including arsenic (As), antimony (Sb), and selenium (Se), pose a severe threat to human health. It is of utmost importance to detect even minute quantities of these toxic elements and this must be efficiently determined to understand their risk. Several traditional and advanced technologies, including atomic absorption spectrometry (AAS), spectrofluorimetry, inductively coupled plasma spectrometry, e-tongues, electrochemical aptasensors, Raman spectroscopy, and fluorescence sensors, among other techniques, have proven highly beneficial in quantifying even the minute concentrations of heavy metals and metalloids in food and dietary supplements. Hence, this review aims to understand the toxicity of these metals and metalloids in food and to shed light on the emerging technologies for their detection.

16 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
UWUddesh Ramesh Wanjari
Uddesh Ramesh Wanjari
Mohamed EladlMohamed Eladl
Mohamed Eladl
MEMohamed El-Sherbiny
Mohamed El-Sherbiny
DEDalia Mahmoud Abdelmonem Elsherbini
Dalia Mahmoud Abdelmonem Elsherbini
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan
The ever-increasing rate of pollution has attracted considerable interest in research. Several anthropogenic activities have diminished soil, air, and water quality and have led to complex chemical pollutants. This review aims to provide a clear idea about the latest and most prevalent pollutants such as heavy metals, PAHs, pesticides, hydrocarbons, and pharmaceuticals—their occurrence in various complex mixtures and how several environmental factors influence their interaction. The mechanism adopted by these contaminants to form the complex mixtures leading to the rise of a new class of contaminants, and thus resulting in severe threats to human health and the environment, has also been exhibited. Additionally, this review provides an in-depth idea of various in vivo, in vitro, and trending biomarkers used for risk assessment and identifies the occurrence of mixed contaminants even at very minute concentrations. Much importance has been given to remediation technologies to understand our current position in handling these contaminants and how the technologies can be improved. This paper aims to create awareness among readers about the most ubiquitous contaminants and how simple ways can be adopted to tackle the same.